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BACKGROUND. Several studies have reported inverse associations between folate
intake and colorectal carcinoma risk. Few were prospective studies and none
evaluated the association between the intake of individual folate vitamers and
colorectal carcinoma risk.
METHODS. The aim of the current study was to investigate the relationship between
dietary folate intake and the risk of colorectal carcinoma in a large prospective
cohort study in The Netherlands comprising 120,852 men and women aged 55– 69
years. After 7.3 years of follow-up, 760 colon and 411 rectal carcinoma cases were
available for analysis. Data processing and analysis used the case– cohort ap-
proach. A new Dutch database was used to estimate intakes of total and individual
folate vitamers.
RESULTS. Analyses adjusted for age, energy intake, family history of colorectal
carcinoma, alcohol, vitamin C, iron, and dietary fiber intake yielded an inverse
association between colon carcinoma risk and total dietary folate intake (rate ratio
[RR]highest vs. lowest quintile, men: 0.73; 95% confidence interval [CI], 0.46 –1.17,
P trend  0.03; women: 0.68; 95% CI, 0.39 –1.20, P trend  0.18). An inverse
association between rectal carcinoma and total dietary folate intake was found
only among men (RR highest vs. lowest quintile, men: 0.66; 95% CI, 0.35–1.21, P
trend  0.03). Analyses showed no clear difference in colorectal carcinoma risk
associated with intake of different folate vitamers.
CONCLUSIONS. Dietary folate intake was related inversely to colon and male rectal
carcinoma risk. Cancer 2002;95:1421–33. © 2002 American Cancer Society.
DOI 10.1002/cncr.10866
KEYWORDS: cohort study, colon carcinoma, rectal carcinoma, folates, diet.
The structure in Figure 1 is known as folic acid, but it is known moreprecisely as pteroylmonoglutamic acid. Folic acid with a fully
oxidized pteridine ring does not occur naturally in significant
amounts. It is the common most stable, synthetic form used for
fortification. Natural folates comprise an extended family of mono-
glutamates and polyglutamates (usually five to seven glutamyl resi-
dues) of pteroic acid, which qualitatively exhibit the biologic activity
of folic acid. The pteridine ring is reduced to give 5,6,7,8-tetrahydro-
folate. These reduced forms can be substituted with a covalently
bonded one-carbon adduct to the nitrogen positions 5 or 10 or
bridged across these two positions. Besides tetrahydrofolate, the most
substituted forms in the human diet are 5-formyl and 5-methyl. Other
frequently occurring folates are 10-formyldihydrofolate and 10-
formylfolic acid. Folic acid from fortified foods or supplements is
absorbed mainly by a saturable pH-dependent process. Before enter-
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ing the blood circulation, folic acid undergoes reduc-
tion to tetrahydrofolate and either methylation or
formylation in the mucosa cells.
Approximately 80% of all food folates exist as
polyglutamates. They must be cleaved into folate
monoglutamates by pteroylpolyglutamate hydrolase
(conjugase), which is present in the intestinal brush
border, before they can be absorbed in the intestine.
Halsted1 hypothesized that after deconjugation of di-
etary polyglutamates to monoglutamates by brush-
border folate hydrolase and transport across the brush
border into the enterocyte, folate polyglutamates are
synthesized intracellularly by folate synthetase. This
maintains the concentration gradient for uptake. Fo-
late polyglutamate is the intracellular form that best
serves the metabolic needs of the cell for folate-de-
pendent reactions and is hydrolyzed intracellularly to
folate monoglutamate for transport across the baso-
lateral membrane to the portal circulation.2,3
Folates are significantly involved in a number of
important processes. The folate-mediated transfer of
one-carbon units from serine provides a major source
of substrate in one-carbon metabolism. Folate coen-
zymes play a role in the synthesis of thymidylate and
purines, the building blocks for RNA and DNA. Con-
sequently, a deficiency of folate in tissues with rapidly
replicating cells results in ineffective DNA synthesis,
leading to reduced cell proliferation, impaired cellular
physiology, and abnormal cytologic morphology. Al-
though it is well established that folic acid deficiency
will retard the growth of established cancers, it does
not necessarily follow that nonneoplastic folate-defi-
cient tissues are less likely to undergo neoplastic
transformation.4 The roles of folate deficiency and
supplementation in colorectal carcinogenesis have
been studied extensively since Freudenheim et al.5
suggested this relationship. They found a lower risk of
colorectal carcinoma in association with high dietary
folate intake in a case– control study. Following this
study, nine case– control studies6 –14 and three pro-
spective cohort studies15–17 investigated the relation
between dietary folate intake and colorectal carci-
noma. In general, a low folate status was associated
with an increased risk of colorectal carcinoma, al-
though the association was not statistically significant
in all studies. Five studies investigated the relation
between folate intake and risk of adenomatous polyps,
the precursor lesions of colorectal carcinoma.10,18 –21
Colorectal carcinomas have different gender distribu-
tions, with essentially similar incidences between the
genders, and a male predominance for rectal carci-
noma.22 However, there are inconsistencies in associ-
ations by subsite of the colon.10
A number of animal studies support the role of
folate deficiency in colorectal carcinogenesis. How-
ever, not all animal studies support the protective role
of folate supplementation in colorectal carcinogene-
sis.4 In one study, dietary folate supplementation did
not have a significant inhibitory effect on aberrant
crypt foci, probably the earliest recognizable precur-
sor lesion and a well established intermediate biomar-
ker of colorectal carcinoma. In another study, folate
supplementation significantly increased the size and
multiplicity of colorectal tumors.4 Some studies have
shown that folate deficiency reduces the development
of colorectal carcinoma in rats.23 Cravo et al.24 con-
cluded from a rat study that folate-deficient rats de-
veloped microscopic and macroscopic colorectal
neoplasms after initiation of dimethylhydrazine, sug-
gesting that folate deficiency affects an early phase of
colorectal carcinogenesis. However, no cancer was ob-
served in two control groups that received a folate-
depleted or control diet. In a subsequent study using
the same model25 a folate-deficient diet was associ-
ated with the development of macroscopic colorectal
tumors. Dietary folate supplementation, up to four
times the dietary requirement, retarded the progres-
sion from microscopic colorectal neoplastic foci to
macroscopic tumors in a dose-dependent manner.
This study suggested that folate also has a modulatory
effect in a later stage of colorectal carcinogenesis.
Levels of dietary folate greater than four times the
dietary requirement did not convey further benefit.
Therefore, supplemental folate may have two distinct
actions. At lower levels of supplementation beyond
the dietary requirement, it possesses an inhibitory
effect on the genesis of microscopic foci of neoplasia.
It also slows the progression of macroscopic neo-
plasms from microscopic neoplasms.4 The relation-
ship between blood levels of folate and colorectal car-
cinoma risk is less well defined than that observed
between dietary folate intake and colorectal carci-
FIGURE 1. Structure of folic acid.
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noma risk.4 Results from small folate intervention tri-
als are promising. Three large multicenter trials are
underway to determine the chemopreventive role of
folate supplementation in colorectal carcinogenesis.4
In all epidemiologic studies, dietary folate intake
was based on the total folate content of foods, usually
determined by microbiologic assay. Folates comprise
an extended family of monoglutamates and polyglu-
tamates of pteroic acid, all qualitatively exhibiting the
biologic activity of folic acid. Many studies have de-
termined that the relative bioavailability of polygluta-
mates versus corresponding monoglutamates ranges
from 25% to 100%.26 Several studies have determined
the relative bioavailability of the most abundant folate
monoglutamates, which may vary between 70% and
129% relative to folic acid.26 One would expect a dif-
ference in risk associated with the intake of different
folate vitamers, because of the wide range in bioavail-
ability. No epidemiologic studies have investigated the
association between individual folate vitamers and
colorectal carcinoma.
In the current study, we investigated the associa-
tion between the dietary intake of folates and the risk
of colorectal carcinoma in The Netherlands Cohort
Study on diet and cancer (NLCS). Separate analyses
were performed for colorectal carcinoma, for both
men and women, and for different subsites of the
colon. Analyses were done for total dietary folate in-
take as well as for the intake of individual folate vita-
mers. The interaction with the intake of methionine
and alcohol was taken into account.
MATERIALS AND METHODS
Cohort
The NLCS is a population-based prospective cohort
study that was started in The Netherlands in 1986 and
comprised 58,279 men and 62,573 women. The study
population originated from 204 municipal population
registries and had an age range of 55– 69 years at
baseline. At baseline, all participants completed a self-
administered mailed questionnaire on habitual di-
etary intake, dietary supplement use, lifestyle charac-
teristics, medical history, and other potential risk
factors for cancer. The case– cohort approach was
used for data processing and analysis. The case–
cohort design randomly selects a subcohort from the
entire cohort, which provides a comparison group at
each disease occurrence time, i.e., those subjects in
the subcohort still at risk for the disease under study at
a given failure time function as controls for the occur-
ring failure whether that failure occurs inside or out-
side the subcohort. This design allows the comparison
group to be selected in advance of cohort follow-up.
This is a distinct advantage because the subcohort can
be used to monitor the achievement of intervention
goals and the collection and processing of covariate
information for all controls (the subcohort members)
can be started immediately on inception. The subco-
hort consisted of 3500 subjects (1688 men and 1812
women) who were followed up biennially for vital
status information. A detailed description of the de-
sign and characteristics of the cohort study has been
reported previously.27,28
Follow-Up for Cancer
Follow-up for incident cancer was established by
record linkage with all regional cancer registries in
The Netherlands and the national pathology register
(PALGA). The method of record linkage has been re-
ported previously.29 Follow-up was restricted to colon
or rectal carcinoma incidence in the period from Sep-
tember 1986 to December 1992. During these 7.3 years
of follow-up, 807 microscopically confirmed incident
colon carcinoma and 453 rectal carcinoma cases were
diagnosed. Subjects with incomplete or inconsistent
dietary data were excluded from the analysis. Details
of this procedure have been reported elsewhere.30 Af-
ter excluding subjects who reported a history of car-
cinoma other than skin carcinoma in the baseline
questionnaire and subjects with colon and rectal car-
cinoma other than carcinoma, 760 colon carcinoma
and 411 rectal carcinoma cases remained for analysis.
Prevalent cancer cases other than skin carcinoma
were excluded from the subcohort as well, leaving
3123 subcohort members for analysis. Completeness
of follow-up of cancer incidence was more than 96%30
and no subcohort members were lost to follow-up.
Dietary Intakes
A 150-item semiquantitative food frequency question-
naire (FFQ) was used to collect data on the habitual
consumption of foods and beverages in the year pre-
ceding the start of the study. The questionnaire was
validated against a 9-day diet record.30 The validity
was investigated in a subgroup of the cohort (59 men
and 50 women). A dietary record, kept over three
3-day periods, 4 –5 months apart, served as the refer-
ence method. Pearson correlation coefficients be-
tween nutrient intakes assessed by the record and the
FFQ completed after ranged from 0.40 for vitamin B1
to 0.86 for alcohol intake, with correlations for most
nutrients between 0.6 and 0.8. Intake of -carotene
was based on recent analytical data compiled by Gold-
bohm et al.31 Folate data were derived from a vali-
dated liquid chromatography trienzyme method32
used to analyze the 125 most important Dutch foods
contributing to folate intake.33 Vegetables, fruit, and
potatoes provide greater than 33% of the daily dietary
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folate intake (22%, 6%, and 7% respectively). Bread,
milk products, meat, and meat products supply an-
other 33% of the daily dietary folate intake (19%, 9%,
and 11%, respectively).33 The most abundant folate
vitamers in foods were evaluated including
tetrahydrofolate (H4folate), 5-methyltetrahydrofolate
(5-CH3-H4folate), 5-formyltetrahydrofolate (5-CHO-
H4folate), 10-formylfolic acid (10-HCO-folic acid), 10-
formyldihydrofolate (10-HCO-H2folate), and folic acid,
as well as the grouped folates total monoglutamates
(H4folate, 5-CH3-H4folate 5-CHO-H4folate, 10-HCO-
folic acid, 10-HCO-H2folate, and folic acid) and total
polyglutamates (H4folate, 5-CH3-H4folate 5-CHO-
H4folate, 10-HCO-folic acid, 10-HCO-H2folate, and fo-
lic acid). Not all food products were analyzed for in-
dividual vitamers. Folate intake from foods analyzed
for individual vitamers covered 90% of total folate
intake. The mean daily intakes of all other relevant
nutrients were calculated using the computerized
Dutch food composition table.34
Population for Analysis
Ultimately, 760 colon carcinoma cases (400 men, 360
women), 411 rectal carcinoma cases (259 men, 152
women), and 3123 subcohort members (1525 men,
1598 women) were available for analysis. Of all malig-
nant tumors in the colon, 378 (187 men, 191 women)
originated in the proximal part (ICD-O topography35
codes 153.0-1, 153.4-6), 348 (195 men, 153 women)
originated in the distal part (ICD-O codes 153.2-3 and
153.7), 14 were unspecified (ICD-O code 153.9), and 10
had overlapping boundaries (ICD-O code 153.8). Ma-
lignant tumors of the rectosigmoid and/or rectum
(ICD-O codes 154.0 and 154.1) were regarded as rectal
carcinoma cases.
Statistical Analysis
Total folate intake was calculated and categorized into
quintiles according to the distribution in the subco-
hort. Incidence rate ratios (RR) and corresponding
95% confidence intervals (CI) for colon or rectal car-
cinoma were estimated from exponentially distributed
failure time regression models28 (Stata statistical pack-
age, release 6.036). Age-adjusted RRs for colorectal car-
cinoma and their 95% CIs were calculated. Tests for
trend were based on two-sided likelihood ratio tests.
Total energy, alcohol intake, smoking, physical activ-
ity, body mass index, meat consumption, and family
history of colorectal carcinoma were evaluated as po-
tential confounders. In our study, family history of
colorectal carcinoma (yes/no) and alcohol intake were
related to colorectal carcinoma.37 Adjustment was
made for these factors in a multivariate model. Be-
cause energy consumption (kcal/d) is frequently re-
garded as a potential confounder, it this was included
in the multivariate model. In addition, models were
used that adjusted for vitamin C, iron, and dietary
fiber, as these nutrient intakes correlated highly with
folate intake. To investigate whether a potential effect
of total folate was caused by (a) specific folate vita-
mer(s), the association between folate vitamer intake
as a continuous variable and colorectal carcinoma risk
was calculated per increment of 50 g/d. Two sepa-
rate analyses were performed. In the analysis of
monoglutamates, polyglutamates were included si-
multaneously and vice versa. In the analysis for each
specific vitamer (5-methyltetrahydrofolate, 5-formyl-
tetrahydrofolate, 10-formylfolic acid, tetrahydrofolate,
10-formyldihydrofolate, folic acid), all other vitamers
were included simultaneously.
To date, The Netherlands does not fortify foods
with folic acid. An intake of 200 g vegetables and two
pieces of fruit daily is recommended to enhance in-
take of folate and other nutrients. This is approxi-
mately double the amount of fruit and vegetables con-
sumed in 1992 according to the Dutch National Food
Consumption Survey. The current population-based
fruit and vegetable intake accounts for approximately
50 g folate.33 To calculate a possible risk reduction
resulting from an additional folate intake of 50 g/d,
corresponding to the current recommendations of the
Dutch Health Council, the association between folate
intake as a continuous variable and colorectal carci-
noma was calculated per increment of 50 g/d. Addi-
tional analyses were performed after exclusion of can-
cer cases diagnosed in the first year of follow-up,
because preclinical symptoms might have influenced
the dietary habits. Separate analyses were conducted
for subsite-specific colon carcinoma. To evaluate
whether possible beneficial effects of folate might be
limited to subjects with low methionine intake, asso-
ciations between dietary folate intake and colorectal
carcinoma were determined for low versus high me-
thionine intake. The joint effects of low folate intake in
combination with low methionine intake and high
alcohol consumption were considered versus interme-
diate intake and high folate intake along with high
methionine intake and low alcohol intake. Quintiles 1
and 2 were defined as low intake, intermediate intake
was defined as Quintile 3, and high intake as Quintiles
4 and 5. Low and high alcohol intake were defined as
4 g/d or less and 15 g/d or more, respectively, with
5–14 g/d as the intermediate intake.
RESULTS
Table 1 presents the mean daily intake of total folate
and individual folate vitamers, as well as several other
relevant characteristics. The mean age of the subco-
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hort members was 61.4 years for both men and
women. Cases were generally older (by approximately
1.2 years). Among subcohort members, approximately
5% had a family history of colorectal cancer. This
percentage was approximately 10% among cases. Di-
etary folate intake among subcohort members and
cases was comparable. Mean ( SD) dietary folate was
224  73 g/d for men in the subcohort versus 200
 65 g/d for women. Comparable intakes among
subcohort members and cases were also found for
methionine, energy, iron, vitamin C, and dietary fiber.
The percentages of alcohol abstainers among the sub-
cohort members were 15.3% and 32.1% for men and
women, respectively. These percentages were compa-
rable for cases, with the exception of male rectal car-
cinoma cases, for which the percentage of alcohol
abstainers was considerably lower (11.3%). Pearson
correlation coefficients between folate intake and
iron, vitamin C, and dietary fiber intake were 0.67,
0.53, and 0.60, respectively.
Table 2 shows the association between dietary
folate intake and colon carcinoma. Generally, higher
total dietary folate intake was related to a lower risk of
colon carcinoma. However, among men, the RR in-
creased again toward unity in the highest quintile of
folate intake compared with the fourth quintile. Age-
adjusted and multivariate analyses (including age, al-
cohol intake, energy intake, and family history of colo-
rectal carcinoma) yielded comparable results. When
iron intake, vitamin C intake, and dietary fiber intake
were also included in the multivariate analyses, RRs
were considerably more inverse, especially for men. A
multivariate analysis including age, alcohol intake, en-
ergy intake, family history of colorectal carcinoma,
iron intake, vitamin C intake, and dietary fiber intake
revealed a statistical significant inverse association be-
tween dietary folate intake and colon carcinoma risk
for men (RR high vs. low  0.73; 95% CI, 0.46 –1.17, P
trend  0.03). Age-adjusted analysis for women re-
vealed a statistical significant inverse association be-
tween dietary folate intake and colon carcinoma. Ad-
justment with other covariates yielded similar results,
although the P for trend increased. A multivariate
analysis including age, alcohol intake, energy intake,
family history of colorectal carcinoma, iron intake,
vitamin C intake, and dietary fiber intake resulted in
an RR for the highest versus lowest quintile of 0.68
(95% CI, 0.39 –1.20, P trend  0.18). In the continuous
analysis, the RR decreased by approximately 10% in
both men and women for each 50-g increment of
dietary folate intake per day. Exclusion of cases diag-
nosed in the first year of follow-up resulted in some-
what higher RRs.
Table 3 shows the association between dietary
folate intake and rectal carcinoma. Dietary folate in-
take was not related to the risk of rectal carcinoma in
age-adjusted and multivariate analyses including age,
alcohol intake, energy intake, and family history of
colorectal carcinoma. After additional adjustment for
iron intake, vitamin C intake, and dietary fiber intake,
the RRs showed an inverse association between di-
etary folate intake and rectal carcinoma risk among
TABLE 1
Nutrient Intake (Mean  SD) and Other Characteristics among Cases and Subcohort Members: The Netherlands Cohort Study 1986 –1993
Men Women
Subcohort Colon carcinoma Rectal carcinoma Subcohort Colon carcinoma Rectal carcinoma
No. 1525 400 259 1598 360 152
Age (yrs) 61.4  4.2 63.0  4.2 62.3  4.1 61.4  4.3 62.7  4.1 62.5  3.8
Family history of colorectal carcinoma (%) 5.6 10.8 10.0 5.4 10.8 6.6
Total folate (g/d) 224  73 218  72 219  73 200  65 191  63 203  69
Monoglutamates (g/d) 70  42 64  37 69  47 56  33 55  31 60  43
Polyglutamates (g/d) 133  42 132  44 130  39 123  39 117  38 123  38
Tetrahydrofolate (g/d) 17  27 15  24 17  32 14  22 14  20 16  29
5-methyltetrahydrofolate (g/d) 131  45 130  47 128  42 123  41 117  41 125  42
5-formyltetrahydrofolate (g/d) 26  10 24  9 25  10 22  8 21  8 22  7
10-formylfolic acid (g/d) 22  9 21  10 22  9 16  5 15  6 15  4
10-formyldihydrofolate (g/d) 10  5 10  6 10  5 9  4 8  4 9  4
Folic acid (g/d) 7  7 6  5 7  6 6  7 6  5 6  5
Methionine (g/d) 1.7  0.4 1.7  0.4 1.7  0.4 1.5  0.4 1.5  0.3 1.5  0.3
Nonalcohol drinkers (%) 15.3 14.8 11.3 32.1 36.7 30.8
Energy (kcal/d) 2160  513 2097  466 2136  445 1690  410 1654  404 1682  399
Iron (mg/d) 13.2  3.2 13.2  3.1 13.3  3.2 11.7  2.7 11.4  2.5 11.6  2.4
Vitamin C (mg/d) 98  42 101  42 102  46 108  44 105  47 111  42
Dietary fiber (g/d) 28.7  8.8 28.3  8.1 28.6  8.5 25.4  7.2 24.6  7.2 24.2  6.0
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men (RR high vs. low  0.66; 95% CI, 0.35–1.21, P
trend  0.03). Among women, there was no inverse
association between dietary folate intake and rectal
carcinoma. In the multivariate analysis, the RR for the
highest versus lowest quintile was 1.26 (95% CI, 0.58 –
2.76, P trend  0.55). RRs were slightly higher when
cases diagnosed in the first year of follow-up were
excluded.
Table 4 shows the results of multivariate analysis
for individual folate vitamers. The RRs for colorectal
carcinomas were lower for polyglutamates than for
monoglutamates. The inverse association between fo-
late polyglutamate intake and rectal carcinoma risk
among men was significant (RR  0.69; 95% CI, 0.52–
0.91). Beneficial effects of folate intake might also vary
between individual vitamers. Compared with other
RRs, there was a strong inverse association between
5-formyltetrahydrofolate intake and colon carcinoma
risk among men (RR  0.25, 95% CI, 0.10 – 0.68).
Colon carcinoma cases were classified according
to specific colon subsites. There were no differences in
the association between folate intake and carcinoma
at specific subsites. Inverse associations were found
for total dietary folate intake and both distal and prox-
imal colon carcinoma in men and women. However,
none were statistically significant (Table 5). For men,
the RRs for the highest versus the lowest quintile were
0.75 (95% CI, 0.39 –1.44) and 0.74 (95% CI, 0.40 –1.35)
for proximal and distal colon carcinoma, respectively.
Among women, the RR values for highest versus low-
est quintile were 0.72 (95% CI, 0.33–1.54) and 0.69
(95% CI, 0.31–1.52) for proximal and distal colon car-
cinoma, respectively.
Results on the interaction between folate and me-
thionine are shown in Table 6. The inverse association
between folate and colorectal carcinoma in the low
methionine intake was limited to men. (P values for
statistical interaction were 0.30 and 0.04 for colon
carcinoma for men and women, respectively, and 0.89
and 0.35 for rectal carcinoma for men and women,
respectively.) Because alcohol acts as a methyl group
antagonist, low intakes of folate and methionine
among substantial alcohol users might be stronger
risk factors for colorectal carcinoma. To examine this
hypothesis, subgroups were formed of those with low
intake levels of folate and methionine and with high
intake levels of alcohol and vice versa. Results are
shown in Table 7. For men, the RR estimates for low
folate-low methionine-high alcohol intakes versus
high folate-high methionine-low alcohol intakes were
1.26 (95% CI, 0.59 –2.70) for colon carcinoma and 2.69
(95% CI, 0.99 –7.29) for rectal carcinoma. For women,
the RR values for high alcohol-low methionine-low
folate intakes versus low alcohol-high methionine-
high folate intakes were 1.01 (95% CI, 0.40 –2.54) for
colon carcinoma and 0.45 (95% CI, 0.14 –1.50) for rec-
TABLE 2
Incidence Rate Ratio (RR) of Colon Carcinoma According to Folate Intake Levels in Multivariate Analyses According to Years of follow-Up:
The Netherlands Cohort Study, 1986 –1993
Quintiles of folate intake
Boundaries (g/d)
Cases in
cohort
Person yrs in
subcohort
7.3 yrs of follow-up First yr excluded
RR (95% CI)a RR (95% CI)b RR (95% CI)c RR (95% CI)c
Men, colon carcinoma
1 ( 168) 98 2042 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 (168–198) 87 2122 0.88 (0.63–1.24) 0.92 (0.65–1.31) 0.84 (0.59–1.21) 1.01 (0.69–1.48)
3 (198–226) 66 2148 0.66 (0.46–0.95) 0.68 (0.46–0.99) 0.59 (0.40–0.88) 0.72 (0.47–1.10)
4 (226–266) 62 2104 0.66 (0.46–0.94) 0.70 (0.47–1.03) 0.58 (0.38–0.90) 0.71 (0.45–1.12)
5 ( 266) 87 2092 0.94 (0.67–1.32) 1.01 (0.68–1.50) 0.73 (0.46–1.17) 0.93 (0.57–1.52)
P value for linear trend 0.22 0.50 0.03 0.29
Increment 50 g/d 0.96 (0.88–1.04) 0.97 (0.88–1.07) 0.88 (0.78–0.99) 0.90 (0.80–1.02)
Women, colon carcinoma
1 ( 150) 91 2257 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 (150–176) 75 2276 0.86 (0.61–1.21) 0.85 (0.59–1.22) 0.84 (0.57–1.23) 0.91 (0.61–1.35)
3 (176–203) 70 2262 0.80 (0.56–1.13) 0.81 (0.55–1.19) 0.79 (0.52–1.21) 0.84 (0.54–1.30)
4 (203–243) 69 2262 0.80 (0.56–1.14) 0.84 (0.56–1.25) 0.81 (0.50–1.33) 0.87 (0.52–1.45)
5 ( 243) 55 2277 0.65 (0.45–0.95) 0.71 (0.46–1.08) 0.68 (0.39–1.20) 0.66 (0.36–1.21)
P value for linear trend 0.01 0.10 0.18 0.18
Increment 50 g/d 0.91 (0.83–1.01) 0.95 (0.84–1.06) 0.96 (0.81–1.13) 0.95 (0.80–1.14)
CI: confidence interval.
a Adjusted for age (yrs).
b Adjusted for for age, alcohol intake, energy intake, and family history of colorectal carcinoma.
c Adjusted for age, alcohol intake, energy intake, family history of colorectal carcinoma, iron intake, vitamin C intake, and dietary fiber intake.
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tal carcinoma. The following unstratified associations
between alcohol and rectal carcinoma risk were
found for men (RR high vs. low  1.21; 95% CI,
0.88 –1.66) and women (1.06; 95% CI, 0.62–1.82).
There were 257 and 143 cases for men and women,
respectively. These results suggest that men who
consume higher amounts of alcohol combined with
inadequate intakes of folate and methionine are at a
higher risk of developing rectal carcinoma. Results
are based on a small number of cases, however.
Among men with low folate intake ( 168 g/d) and
high alcohol intake ( 15 g/d), the risk of rectal
carcinoma was approximately 1.5 times the risk of
rectal carcinoma for men with low folate intake
combined with a low alcohol intake ( 4 g/d; data
not shown).
TABLE 3
Incidence Rate Ratio (RR) of Rectal Carcinoma According to Folate Intake Levels in Multivariate Analyses According to Years of Follow-Up:
The Netherlands Cohort Study, 1986 –1993
Quintiles of folate intake
Boundaries (g/d)
Cases in
cohort
Person yrs in
subcohort
7.3 yrs of follow-up First yr excluded
RR (95% CI)a RR (95% CI)b RR (95% CI)c RR (95% CI)c
Men, rectal carcinoma
1 ( 168) 54 2048 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 (168–198) 64 2124 1.17 (0.78–1.74) 1.19 (0.78–1.79) 1.07 (0.70–1.63) 1.06 (0.68–1.66)
3 (198–226) 46 2142 0.83 (0.54–1.27) 0.80 (0.51–1.26) 0.67 (0.42–1.09) 0.66 (0.40–1.09)
4 (226–266) 46 2108 0.86 (0.56–1.32) 0.86 (0.54–1.36) 0.68 (0.41–1.13) 0.72 (0.42–1.21)
5 ( 266) 49 2103 0.93 (0.61–1.41) 0.94 (0.56–1.58) 0.66 (0.35–1.21) 0.69 (0.36–1.31)
P value for linear trend 0.28 0.33 0.03 0.06
Increment 50 g/d 0.96 (0.87–1.07) 0.96 (0.85–1.09) 0.87 (0.74–1.02) 0.89 (0.76–1.05)
Women, rectal carcinoma
1 ( 150) 29 2261 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
2 (150–176) 30 2276 1.08 (0.63–1.84) 1.17 (0.66–2.09) 1.18 (0.65–2.15) 1.37 (0.73–2.60)
3 (176–203) 30 2270 1.06 (0.62–1.82) 1.18 (0.65–2.16) 1.22 (0.65–2.28) 1.35 (0.69–2.65)
4 (203–243) 32 2267 1.15 (0.68–1.96) 1.26 (0.68–2.36) 1.28 (0.63–2.59) 1.20 (0.56–2.58)
5 ( 243) 31 2280 1.14 (0.67–1.96) 1.28 (0.67–2.48) 1.26 (0.58–2.76) 1.25 (0.54–2.92)
P value for linear trend 0.56 0.40 0.55 0.81
Increment 50 g/d 1.06 (0.93–1.20) 1.10 (0.94–1.28) 1.10 (0.92–1.32) 1.12 (0.92–1.36)
CI: confidence interval.
a Adjusted for age (yrs).
b Adjusted for for age, alcohol intake, energy intake, and family history of colorectal carcinoma.
c Adjusted for age, alcohol intake, energy intake, family history of colorectal carcinoma, iron intake, vitamin C intake, and dietary fiber intake.
TABLE 4
Incidence Rate Ratio (RR) of Colon and Rectal Carcinoma According to an Intake of 50 g/d of Different Folate Vitamers:
The Netherlands Cohort Study, 1986 –1993a
Men Women
Colon carcinoma
RR (95% CI)b
Rectal carcinoma
RR (95% CI)b
Colon carcinoma
RR (95% CI)b
Rectal carcinoma
RR (95% CI)b
Monoglutamates 0.80 (0.65–0.98) 1.02 (0.84–1.24) 1.15 (0.96–1.37) 1.13 (0.87–1.45)
Polyglutamates 0.98 (0.79–1.21) 0.69 (0.52–0.91) 0.78 (0.59–1.01) 1.05 (0.76–1.46)
5-methyltetrahydrofolate 1.03 (0.84–1.27) 0.68 (0.51–0.91) 0.84 (0.62–1.13) 1.08 (0.76–1.53)
5-formyltetrahydrofolate 0.25 (0.10–0.68) 0.53 (0.16–1.74) 0.87 (0.28–2.78) 1.23 (0.26–5.89)
10-formylfolic acid 0.82 (0.40–1.65) 0.96 (0.43–2.13) 0.64 (0.09–4.50) 0.42 (0.04–3.88)
Tetrahydrofolate 0.83 (0.62–1.10) 1.14 (0.82–1.58) 1.30 (1.00–1.68) 1.10 (0.74–1.65)
10-formyldihydrofolate 1.31 (0.36–4.86) 5.07 (1.22–22.04) 1.03 (0.21–5.21) 1.61 (0.18–14.25)
Folic acid 0.35 (0.11–1.15) 0.70 (0.22–2.20) 0.79 (0.30–2.09) 1.22 (0.49–3.07)
CI: confidence interval.
a Two separate analyses were performed. In the analysis of monoglutamates, polyglutamates were included simultaneously and vice versa. In the analysis for each specific vitamer (5-methyltetrahydrofolate,
5-formyltetrahydrofolate, 10-formylfolic acid, tetrahydrofolate, 10-formyldihydrofolate, folic acid), all other vitamers were included simultaneously.
b Adjusted for age, alcohol intake, energy intake, family history of colorectal carcinoma, iron, vitamin C, and dietary fiber.
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DISCUSSION
Dietary folate intake is associated inversely with a risk
of colon carcinoma in men and women and with
rectal carcinoma in men. An inverse association of
folate against rectal carcinoma was not found among
women.
A number of mechanisms are involved in folate-
associated carcinogenesis. First, folate plays a role in a
number of metabolic pathways, such as the biosyn-
thesis of purines and thymidines. Folate deficiency
causes massive incorporation of uracil into human
DNA as well as chromosome breaks, resulting in the
initiation of neoplastic transformation.38 These pro-
cesses returned to normal when individuals received
folic acid supplementation.38 Second, a mutation in
the methylenetetrahydrofolate reductase (MTHFR)
TABLE 5
Incidence Rate Ratios (RR) of Colon Carcinoma According to Quintiles of Folate Intake and Subsite: The Netherlands Cohort Study, 1986 –1993
Mena Womena
Quintiles of folate
intake (g/d)
Proximal colon carcinoma
(186 cases)
RR (95% CI)b
Distal colon carcinoma
(194 cases)
RR (95% CI)b
Quintiles of folate
intake (g/d)
Proximal colon carcinoma
(185 cases)
RR (95% CI)b
Distal colon carcinoma
(152 cases)
RR (95% CI)b
1 ( 168) 1.00 (reference) 1.00 (reference) 1 ( 150) 1.00 (reference) 1.00 (reference)
2 (168–198) 0.87 (0.53–1.42) 0.84 (0.53–1.33) 2 (150–176) 0.84 (0.51–1.40) 0.87 (0.51–1.48)
3 (198–226) 0.66 (0.38–1.15) 0.52 (0.31–0.88) 3 (176–203) 0.81 (0.47–1.42) 0.83 (0.46–1.51)
4 (226–266) 0.67 (0.38–1.21) 0.50 (0.28–0.89) 4 (203–243) 1.03 (0.55–1.95) 0.68 (0.33–1.41)
5 ( 266) 0.75 (0.39–1.44) 0.74 (0.40–1.35) 5 ( 243) 0.72 (0.33–1.54) 0.69 (0.31–1.52)
P value for trend 0.24 0.08 0.66 0.26
CI: confidence interval.
a Proximal colon carcinoma ICD codes: 153.0, 153.1, 153.4, 153.5, 153.6; distal colon carcinoma ICD codes: 153.2, 153.3, 153.7.
b Adjusted for age, alcohol intake, energy intake, family history of colorectal carcinoma, iron intake, vitamin C intake, and dietary fiber intake.
TABLE 6
Incidence Rate Ratios (RR) of Colon and Rectal Carcinoma According to Quintiles of Folate Intake and Level of Methionine Intake;
The Netherlands Cohort Study, 1986 –1993
Men Women
Quintiles of folate
intake (g/d)
Low methionine
intake (< 1.58 g/d)
RR (95% CI)a
High methionine
intake (> 1.78 g/d)
RR (95% CI)a
Quintiles of folate
intake (g/d)
Low methionine
intake (< 1.38 g/d)
RR (95% CI)a
High methionine
intake (> 1.56 g/d)
RR (95% CI)a
Colon carcinoma
176 cases 142 cases 146 cases 134 cases
1 ( 168) 1.00 (reference) 1.00 (reference) 1 ( 150) 1.00 (reference) 1.00 (reference)
2 (168–198) 0.85 (0.52–1.38) 1.09 (0.33–3.60) 2 (150–176) 0.80 (0.45–1.42) 0.71 (0.29–1.73)
3 (198–226) 0.46 (0.26–0.84) 1.17 (0.35–3.85) 3 (176–203) 1.06 (0.56–2.02) 0.41 (0.17–0.99)
4 (226–266) 0.41 (0.19–0.87) 0.95 (0.29–3.12) 4 (203–243) 1.72 (0.76–3.87) 0.48 (0.20–1.17)
5 ( 266) 0.40 (0.15–1.10) 1.46 (0.45–4.68) 5 ( 243) 0.50 (0.16–1.56) 0.45 (0.17–1.20)
P value for
trendb 0.0004 0.34 0.76 0.09
Rectum carcinoma
109 cases 91 cases 51 cases 60 cases
1 ( 168) 1.00 (reference) 1.00 (reference) 1 ( 150) 1.00 (reference) 1.00 (reference)
2 (168–198) 1.10 (0.61–1.98) 2.06 (0.43–9.83) 2 (150–176) 1.21 (0.51–2.87) 0.48 (0.48–4.18)
3 (198–226) 0.71 (0.36–1.42) 1.12 (0.22–5.65) 3 (176–203) 1.30 (0.50–3.40) 0.53 (0.16–1.80)
4 (226–266) 0.43 (0.16–1.11) 1.05 (0.21–5.13) 4 (203–243) 1.97 (0.62–6.21) 0.57 (0.17–1.89)
5 ( 266) 0.50 (0.17–1.50) 1.23 (0.25–6.01) 5 ( 243) 0.86 (0.18–4.04) 0.74 (0.19–2.85)
P value for
trendb 0.02 0.32 0.63 0.97
CI: confidence interval.
a Adjusted for age, alcohol intake, energy intake, family history of colorectal carcinoma, iron intake, vitamin C intake, and dietary fiber intake.
b Test for trend based on separate models stratified by methionine level.
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gene causes reduced enzyme activity, leading to low
plasma folate levels. Although the polymorphism is
disadvantageous in homozygous carriers with low fo-
late levels, its presence may reduce colorectal carci-
noma in individuals with an adequate folate sup-
ply.38 – 40 The findings, however, have not been
consistent.41 Third, folate is essential for methylation
reactions in humans. Reduced methylation of DNA,
caused by inadequate cellular levels of the methyl
donor S-adenosylmethionine, may contribute to loss
of normal controls on protooncogene expression. Be-
cause production of S-adenosylmethionine depends
on both methionine and folate, diets deficient in these
factors may cause an imbalance in DNA methylation.
In humans, hypomethylation of DNA has been ob-
served in individuals with colorectal carcinomas.42
Site-specific hypermethylation also may be important
in tumorigenesis.43– 45 However, genomic and gene-
specific DNA hypomethylation is still considered to be
an important epigenetic phenomenon in neoplastic
transformation.4 Sufficient methionine intake may
also reduce the risk of colorectal carcinoma15,19 and
possibly attenuate the beneficial role of folate. The
association between folate and colorectal carcinoma
may be stronger in individuals with a low intake of
methionine. A protective effect of folate and methio-
nine against colorectal carcinoma may be impaired by
the suppressive effect of high alcohol consumption
on methyl-group metabolism.46 –50 Therefore, alcohol
acts as a methyl-group antagonist. In combination
with low folate and low methionine intake, heavy
drinkers might be at greatest risk of colorectal carci-
noma.
Many case– control studies have found inverse as-
sociations between folate intake and the risk of colo-
rectal carcinoma.6 –14 These studies found on average
a 35% reduction in the risk of developing colorectal
carcinoma in subjects with the highest dietary folate
intake compared with those with the lowest intake.4
Five studies found a statistically significant reduction.
Evidence from three prospective studies15–17 supports
an inverse association between folate intake and the
risk of colon carcinoma. No prospective studies have
been reported on rectal carcinoma. In the Health Pro-
fessionals Follow-Up Study, dietary folate intake was
not statistically significantly related to the risk of colon
carcinoma with an RR (highest vs. lowest quintile) of
0.86,15 nor did the Nurses’ Health Study find a statis-
tically significant association with colon carcinoma.
The multivariate RR for highest versus lowest quintile
in the Nurses’ Health Study was 0.82 (95% CI, 0.56 –
1.20). The inverse association in the current study was
stronger with RRs of about 0.70. This stronger associ-
ation in our study occurred when we controlled for
iron intake in the multivariate analysis, especially for
men. In cohort studies reported previously, the use of
supplemental folic acid for more than 15 years was
associated with a lower risk of colon carcinoma. In the
NLCS, 22% of the study population used vitamin B
supplements.51 However, due to legislative restrictions
in The Netherlands, it was not allowed until 1994 to
use folic acid in vitamin supplements. Therefore, the
overall effect of folic acid supplements in this cohort is
negligible. One of the strengths of our study is its
prospective design. Preclinical symptoms are not
likely to have influenced the dietary habits, because
results were not much affected after exclusion of cases
diagnosed in the first year of follow-up. Furthermore,
selection bias was not likely because the follow-up of
cases and subcohort members was almost complete.
TABLE 7
Incidence Rate Ratios (RR) of Colon and Rectal Carcinoma According to a Combination of Folate Intake, Methionine Intake, and Alcohol Intake:
The Netherlands Cohort Study, 1986 –1993a
Combined intake
Colon carcinoma Rectal carcinoma
Men (85 cases)
RR (95% CI)b
Women (67 cases)
RR (95% CI)b
Men (47 cases)
RR (95% CI)b
Women (32 cases)
RR (95% CI)b
High folate-high methionine-low alcohol 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Intermediate alcohol-methionine-folate 0.83 (0.26–2.67) 0.47 (0.10–2.18) 1.59 (0.37–6.90) 0.79 (0.16–3.82)
Low folate-low methionine-high alcohol 1.26 (0.59–2.70) 1.01 (0.40–2.54) 2.69 (0.99–7.29) 0.45 (0.14–1.50)
CI: confidence interval.
a Low alcohol intake is defined as  4 g/d and high alcohol intake is defined as  15 g/d. Low and high intakes of folate and methionine are Quintiles 1, 2 and 4, 5, respectively. Intermediate intakes of folate and
methionine are Quintiles 3. Intermediate alcohol intake is defined as between 5 and 14 g/d. Low intake of folate are Quintiles 1  2 ( 198 g/d for men,  176 g/d for women). High intake of folate are Quintiles
4  5 ( 226 g/d for men,  203 g/d for women). Intermediate intake of folate are Quintiles 3 (198 –226 g/d for men and 176 –203 g/d for women). Low intake of methionine are Quintiles 1  2 ( 1.58 g/d
for men,  1.38 g/d for women). High intake of methionine are Quintiles 4  5 ( 1.78 g/d for men,  1.56 g/d for women). Intermediate intake of methionine are Quintiles 3 (1.58 –1.78 g/d for men and 1.38 –1.56
g/d for women).
b Adjusted for age, energy intake, family history of colorectal carcinoma, iron intake, vitamin C intake, and dietary fiber intake.
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Another strength of the current study was the use of a
newly compiled folate database with food folate val-
ues. Based on Dutch products, the folate database was
established with a validated trienzyme high-perfor-
mance liquid chromatography method preceded by
an affinity chromatography cleanup step.33 Many
comparisons were made and some significant associ-
ations might be the result of chance.
This is the first epidemiologic study to estimate
associations between the intake of individual folate
vitamers and cancer risk. Beneficial effects of folate
intake might be stronger for folate monoglutamates
than for folate polyglutamates because the relative
bioavailability of polyglutamates versus their corre-
sponding monoglutamates might be as low as 25%.26
Analyses showed no clear difference in colorectal car-
cinoma risk associated with intake of polyglutamates
versus monoglutamates. Among the associations be-
tween individual folate vitamers and colon or rectal
carcinoma risk, a statistically significant inverse asso-
ciation between 5-formyltetrahydrofolate intake and
colon carcinoma risk among men was found. The
inverse association between 5-formyltetrahydrofolate
intake and colon carcinoma risk among men seemed
to be stronger than that between the other vitamers
and colon carcinoma risk. This cannot be explained
on the basis of current knowledge and might be
the result of chance. Stern et al.52 concluded that
the intestinal tissue has the capacity to convert
5-formyltetrahydrofolate into 5-methyltetrahydrofo-
late. Conversion of 5-formyltetrahydrofolate into
5-methyltetrahydrofolate is unimpaired in folate-ade-
quate persons homozygous for the C677T mutation in
the MTHFR gene. As a result, there might be no dif-
ference in working mechanisms of these vitamers. The
intakes of folic acid, 10-formyldihydrofolate tetrahy-
drofolate, and 10-formylfolic acid were low in this
study. This resulted in much larger CIs (less statistical
stability) of the observed RRs than those of the vita-
mers with a relatively high intake Also, when testing as
many associations simultaneously, one significant ob-
servation is compatible with chance.
An inverse association between folate and colo-
rectal carcinoma at low methionine intake seemed to
be limited to men, although the interaction was not
statistically significant. A greater benefit of folate at
low methionine intake underlines the role of folate in
methionine synthesis. An insufficient folate level com-
bined with low methionine intake might result in in-
adequate DNA methylation, leading to a greater risk of
colon carcinoma, as hypomethylation is regarded as
one of the earliest events in colon caricinogenesis.
Giovannucci et al.16 found a statistically significant
interaction between folate and methionine in the
Nurses’ Health Study (P 0.005). This became weaker
when folic acid supplement users were excluded from
the analysis (P  0.02), suggesting a stronger effect
with higher folate intake at low methionine intake
levels. The current study considered only dietary fo-
late intakes, which might explain the weaker interac-
tion effects. Folate deficiency has not been shown
unequivocally to induce genomic or site-specific DNA
hypomethylation but is still considered as a possible
mechanism. Cravo et al.53,54 observed that folate sup-
plementation significantly reversed genomic DNA hy-
pomethylation of the colonic mucosa. Kim et al.55
reported that DNA methylation underwent improve-
ment with folate supplementation. However, methyl-
ation also improved with a placebo, which might have
been caused by participants who were informed about
the possible cancer-protective effects of folate. The
results of our study do not support a role of folate in
DNA methylation. A stronger inverse association be-
tween folate and colorectal carcinoma at low methio-
nine intake, which underlines the role of folate in
methionine synthesis, was not confirmed by a statis-
tically significant interaction.
We found a somewhat higher risk of colon carci-
noma among men with a high alcohol intake com-
bined with low folate and methionine intakes, al-
though this was not significant. The effect was
stronger for rectal carcinoma. In the Health Profes-
sionals Follow-Up Study, Giovannucci et al.15 found
an approximately twofold higher risk of colon carci-
noma among men with a high alcohol intake com-
bined with low folate and methionine intakes, com-
pared to men with low alcohol intake combined with
high folate and methionine intakes. Mean alcohol in-
take for the high intake level in our study was 32 g/d,
slightly higher than the highest intake level in the
Health Professionals Study, which was 29 g/d. The
approximately 2.5 times higher folate intake level in
the Health Professionals Follow-Up Study in the high
intake group (755 g/d vs. 290 g/d in our study for
the high folate intake level) might explain the differ-
ences in RR. Our study found a 2.5 times higher risk of
rectal carcinoma among men with a high alcohol in-
take combined with low folate and methionine in-
takes. The inverse association between high alcohol
intake combined with low folate and methionine in-
take and rectal carcinoma risk among women is hard
to explain. This subgroup had the smallest number of
cases, yet the absence of an inverse association be-
tween folate intake and rectal carcinoma risk among
women would not plead for an effect of the folate
antagonist alcohol. However, unstratified analysis re-
vealed no association between alcohol consumption
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and rectal carcinoma risk among women. Other stud-
ies have found elevated risks associated with alcohol
predominantly in the rectum or distal colon.42 The
RRs for distal colon carcinoma in our study were not
higher than those for total colon carcinoma (data not
shown) among subjects with a high alcohol intake
combined with low folate and methionine intakes.
There are subsite-specific differences in colon
carcinoma risk associated with vegetable consump-
tion.37 However, this was not observed for folate
intake, suggesting that another component in vege-
tables might be responsible for this effect. We in-
cluded many dietary and nondietary determinants
of colorectal carcinoma as potential confounders in
the multivariate models. It is still possible, however,
that another factor, not controlled for in our analy-
sis, might be involved. A striking finding of the cur-
rent study was a strong confounding effect of iron
intake in the associations between folate intake and
colorectal carcinoma among men, which was not
found among women. This is consistent with find-
ings by Nelson et al.56,57 and Stevens et al.,58 who
reported positive associations between iron stores
and dietary iron intake and between colon carci-
noma and colonic adenoma, which might only ap-
ply to men. In our study, heme-iron from meat and
meat products is the most important source that
might be associated with an increased risk of colo-
rectal carcinoma. It has been hypothesized that iron
could catalyze the production of oxygen radicals,
which can function as proximate carcinogens. Iron
may be a limiting nutrient for the growth and de-
velopment of cancer cells. Therefore, excess iron
may stimulate the growth of cancer cells. Indicators
of body iron stores are serum ferritin and total iron-
binding capacity, which is related inversely to serum
ferritin levels. Physiologically, women have lower
iron stores, which might explain differences in can-
cer development. The presence of metals (Fe2) in-
creases folate loss.59 In addition, Free radical inter-
mediates may be involved in the chemical oxidation
of reduced pterins by Fe3.60 This means that the
biologic activity of folate may be reduced by the
presence of iron.
Because many folate-containing foods also con-
tain other possible risk-reducing vitamins that might
affect our findings, associations between folate and
colorectal carcinoma were investigated in subjects
with low and high intakes of vitamin E, vitamin C,
-carotene, and vitamin A. No statistically significant
interactions were found (data not shown), which un-
derline the independent effect of dietary folate. Pear-
son correlation coefficients of folate with vitamin E,
vitamin C, -carotene, and vitamin A were, respec-
tively, 0.28, 0.53, 0.50, and 0.68 for men and 0.32, 0.58,
0.52, and 0.66 for women. Given these relatively low
correlations, the problem of multicollinearity proba-
bly did not exist.
In summary, the authors found evidence for an
inverse association between dietary folate intake and
colon carcinoma risk in men and women and rectal
carcinoma risk in men only. Risk appeared to be in-
dependent of vitamins A,C,E, and -carotene intakes
as a proxi for fruit and vegetables. Analyses showed no
clear difference in colorectal carcinoma risk associ-
ated with intake of different folate vitamers. The ben-
eficial role of folate may not be limited to persons with
a low methionine intake. The antagonism between
alcohol and methyl group metabolism was most pro-
nounced in men and mainly confined to rectal carci-
nomas.
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